Home On Pins and Needles

On Pins and Needles

Hello! I’m Lydia Kim, the digital content editor for American Nurse. Part of my role is expanding the types of content and the diversity of voices included on our journal’s digital platforms. I’ve also been tasked with creating original content that’s meaningful to our readers. As a trained linguist, I’m passionate about language, and I’m especially interested in how language and healthcare intersect. In addition to sharing information about the latest healthcare news or advocacy events that impact your daily nursing practice, I hope On Pins and Needles can be a platform for sharing my passion for the language and offer you a new perspective.

If you have any suggestions for my blog, please submit a comment, or e-mail me at LKim@healthcommedia.com. I look forward to hearing from you!

Blog Posts

First FDA approved treatment for thyroid eye disease

The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults with thyroid eye disease (TED). TED is a rare disorder which causes the...

Increase in confirmed coronavirus cases in US

Over the weekend, there was an increase in the amount of confirmed coronavirus cases to hit the United States; currently, there are five confirmed cases. Additionally, there has been an increase in both the amount...

Alcohol-related mortality rates on the rise

A new study published in Alcoholism Clinical & Experimental Research reveals that the amount of alcohol-related deaths in the United States has increased between 1999 and 2017. The study examined death certificates of people 16+...

FDA to host meeting on the development of products for rare diseases

On February 24, the U.S. Food and Drug Administration (FDA) is hosting a public meeting to celebrate FDA Rare Disease Day 2020 which will focus on what the future holds for the product development...

Study fails to show benefit of adding vitamin C to treatment of septic shock

A study recently published in the Journal of the American Medial Association aimed to examine if a treatment combination of vitamin C, hydrocortisone, and thiamine would lead to a “rapid resolution of septic shock”...

First coronavirus patient identified in U.S.

On the heels of today's earlier post regarding the increase mortality rates in Wuhan, China from the coronavirus, The New York Times (NYT) just released an article detailing news that the first U.S. patient with coronavirus has...

Deaths from coronavirus rise

In the past 24 hours, news coverage of the coronavirus in Wuhan, China has become more and more rampant. I first heard of the outbreak from my husband last night before bed, and was...

New findings from the American Cancer Society on reduced cancer mortality rates

Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to 2017 in the US. Additionally, between 2016 to 2017, there was a...

Linguistics in healthcare: Why it matters

MK Hedrick is a former colleague of mine who works in healthcare market research. When we worked together, we were tasked with trying to understand the ins and outs of different online disease communities...

The Parkinson’s Foundation launched first-ever Nurse Fellowship program

The Parkinson’s Foundation recently announced the launch of its new Parkinson’s Nurse Fellowship program in the U.S. The fellowship award will offer support up to $95,000 “in salary, fringe benefits, malpractice insurance, research allowance, and...

First targeted therapy for rare mutation of gastrointestinal stromal tumors

The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment of adult patients with metastatic gastrointestinal stromal tumor (GIST) with the “platelet-derived growth factor...

First FDA-approved treatment for preventing Ebola virus

In late December 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Merck’s Ervebo, the first FDA-approved vaccine to prevent Ebola virus disease. The FDA Deputy Commissioner for Policy, Legislation, and International...

New guidelines for the management of school-based asthma

The Community Preventative Services Task Force (CPSTF) recently released new recommendations around the management of school-based asthma. These management strategies aim to reduce the amount of hospitalizations and emergency room visits from children and...